Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FOESY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TGF-beta-R antagonist
|
|||||
| Synonyms |
TGF beta receptor antagonist ASGR1 antibody conjugate (Silverback Therapeutics); ASGR1-TGFbetaR
Click to Show/Hide
|
|||||
| Organization |
Silverback Therapeutics, Inc.; ARS Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Hepatic fibrosis/cirrhosis [ICD11:DB93]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Asialoglycoprotein receptor 1 (ASGR1)
|
Antigen Info | ||||
| Payload Name |
TGFBR2 antagonist
|
Payload Info | ||||
| Therapeutic Target |
TGF-beta receptor type-2 (TGFBR2)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.